04:37 PM EDT, 04/03/2025 (MT Newswires) -- Lifecore Biomedical ( LFCR ) late Thursday reported a loss of $0.47 per diluted share in fiscal Q3, compared with earnings of $0.42 a share a year earlier.

Two analysts polled by FactSet expected a loss of $0.15.

Revenue for the quarter ended Feb. 23 was $35.2 million, down from $35.7 million a year earlier.

Two analysts surveyed by FactSet expected $33.2 million.

The company reiterated its fiscal 2025 revenue guidance of between $126.5 million and $130.0 million.

Two analysts surveyed by FactSet expected $128.4 million.